These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 9458077

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Genetic analysis of prostatic atypical adenomatous hyperplasia (adenosis).
    Doll JA, Zhu X, Furman J, Kaleem Z, Torres C, Humphrey PA, Donis-Keller H.
    Am J Pathol; 1999 Sep; 155(3):967-71. PubMed ID: 10487854
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Premalignant lesions of prostate and their association with nodular hyperplasia and carcinoma prostate.
    Rekhi B, Jaswal TS, Arora B.
    Indian J Cancer; 2004 Sep; 41(2):60-5. PubMed ID: 15318010
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Genetic relationship among atypical adenomatous hyperplasia, bronchioloalveolar carcinoma and adenocarcinoma of the lung.
    Morandi L, Asioli S, Cavazza A, Pession A, Damiani S.
    Lung Cancer; 2007 Apr; 56(1):35-42. PubMed ID: 17241687
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Atypical adenomatous hyperplasia (adenosis) of the prostate: DNA ploidy analysis and immunophenotype.
    Lopez-Beltran A, Qian J, Montironi R, Luque RJ, Bostwick DG.
    Int J Surg Pathol; 2005 Apr; 13(2):167-73. PubMed ID: 15864380
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Differentiation of atypical adenomatous hyperplasia and adenocarcinoma of the lung by use of DNA ploidy and morphometric analysis.
    Yokozaki M, Kodama T, Yokose T, Matsumoto T, Mukai K.
    Mod Pathol; 1996 Dec; 9(12):1156-64. PubMed ID: 8972475
    [Abstract] [Full Text] [Related]

  • 15. DNA fingerprint detection of somatic mutations in benign prostatic hyperplasia and prostatic adenocarcinoma.
    Werely CJ, Heyns CF, Van Velden DJ, Van Helden PD.
    Genes Chromosomes Cancer; 1996 Sep; 17(1):31-6. PubMed ID: 8889504
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Preneoplastic lesions of the prostate-clinical, pathological and molecular biological aspects.
    Nasir A, Copeland J, Gillespie JW, Chughtai OR, Andrawis R, Kaiser HE, Manyak MJ.
    In Vivo; 2002 Sep; 16(6):557-66. PubMed ID: 12494901
    [Abstract] [Full Text] [Related]

  • 18. Premalignant lesions of the prostate.
    Bostwick DG.
    Semin Diagn Pathol; 1988 Aug; 5(3):240-53. PubMed ID: 3051237
    [Abstract] [Full Text] [Related]

  • 19. Proliferative activity, p53 expression and loss of heterozygosity on 3p, 9p and 17p in atypical adenomatous hyperplasia of the lung.
    Kitaguchi S, Takeshima Y, Nishisaka T, Inai K.
    Hiroshima J Med Sci; 1998 Mar; 47(1):17-25. PubMed ID: 9583279
    [Abstract] [Full Text] [Related]

  • 20. A subset of lung adenocarcinomas and atypical adenomatous hyperplasia-associated foci are genotypically related: an EGFR, HER2, and K-ras mutational analysis.
    Sartori G, Cavazza A, Bertolini F, Longo L, Marchioni A, Costantini M, Barbieri F, Migaldi M, Rossi G.
    Am J Clin Pathol; 2008 Feb; 129(2):202-10. PubMed ID: 18208799
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.